consecutive patients with an underexpanded stent despite high pressure balloon inflation were included. The mean age was 70.4±10.4 years, 11 patients (61.2%) were male, and diabetes mellitus was present in 9 patients (50.0%) Target lesions included 1 (5.6%) in the distal left mainstem, 11 (61.1) in the left anterior descending artery, 3 (16.7%) in the left circumflex and 3 (16.7%) right coronary artery. The mean catheter size was 1.2±0.4 (range 0.9-2.0mm) and a mean of 3610±1824 laser pulses were required for optimal expansion. Optimal stent dilatation was achieved in 17 cases (94.4%), with an improvement in minimum lumen diameter measured by QCA (1.59mm at baseline to 2.78mm post-procedure) and minimum stent area measured by IVUS (3.80mm2 to 7.99mm2). Periprocedural MI was observed in 2 patients and transient slow flow in 1 patient following ELCA. During follow-up, MACE occurred in 1 patient (5.5%) who underwent TLR.
Background:
The amount of neointimal hyperplasia (IH) following drug-eluting stent (DES) implantation correlates with the potency of the anti-proliferative drug, its kinetic release as well as some individual characteristics, as the presence of diabetes mellitus (DM). Recently, some publications have suggested a continuous growth of IH following DES, which in some cases, might result in late "catch-up". The aim of this study was to assess, by means of serial intravascular ultrasound (IVUS) the temporal course of IH formation following the implantation of two different generation of DES (durable-polymer sirolimus-eluting stent [SES] and biodegradable-polymer biolimuseluting stent [BES] ) Methods: Twenty-five pts with single de novo lesions in native coronary arteries, with reference vessel diameter between 2.5 and 3.5 mm were treated with Cypher-SES (n=12) and Biomatrix-BES (n=13), and underwent IVUS evaluation post procedure, at a mean of 9 months and 5 years. Results: The mean age was 59 years, with 28% of DM. Baseline characteristics did not differ between the groups. Overall, percentage of IH obstruction and IH volume markedly increased from mid to long-term FU(percentage IH obstruction of 1.3% at 1st FU vs. 4.8% 2nd FU, p=0.002; mean IH volume 1.8 mm3 at 1st FU vs. 6.3 mm3 2nd FU, p=0.005). There was no significant difference in the variation (Δ) of vessel volume, lumen volume and percentage of IH obstruction between DES. In a separate analysis, sorting out patients according to diabetic status (7 diabetics and 18 nondiabetics), a more pronounced IH increase among diabetics was noticed (mean IH volume at 2nd FU 10.15 mm3 DM vs. 5.11 mm3 non-DM, p=0.02; percentage of IH obstruction at 2nd FU 8.3% DM vs. 3.5% non-DM, p=0.02).
Conclusion:
The present serial IVUS assessment represents the longest serial invasive assessment of two generations DES with durable and biodegradable polymers. The findings of this study support the occurrence of continuous IH growth following the implantation of DES, these observations seem to be particularly A training set of registered OFDI-histology pairs (n=150) was used to develop a prediction model using quadratic discriminant analysis. Inputs to the model included attenuation, backscattering, and wavelength dependent attenuation. Model output is the probability for each pixel being assigned to lipid, calcium, fibrous, adventitial fat, or noise. The resultant spectroscopic diagnosis was compared to histological diagnosis. Results: Using correlated OFDI and histology images, depth resolved spectral analysis was able to classify lipid, calcium, fibrous regions, adventitial fat, and noise with significant (p<0.001) areas under the receiver operator characteristic curve (0.87, 0.83, 0.97, 0.89, and 0.99 respectively). Although the backscattering and attenuation coefficients were significantly different between tissue types (p<0.001), the addition of spectral parameters increase the classification accuracy of lipid (AUC=0.87 with spectral parameters, AUC=0.84 without) and adventitial fat (AUC=0.89 with spectral parameters, AUC=0.87 without), p<0.05.
TCT-649

Conclusion:
We have developed a method for classification of intracoronary OFDI pullbacks. This method can increase the contrast of OFDI intracoronary images and facilitate a rapid comprehensive visualization of OFDI datasets, which can potentially improve OFDI diagnosis and/or assist in guiding therapeutic procedures.
TCT-650
In Background: Intravascular imaging with Fourier domain optical coherence tomography produces high-resolution images (10-20 μm) of coronary atherosclerosis. The LipiScan IVUS Coronary Imaging System combines co-registered grayscale intravascular ultrasound (IVUS) with near infrared spectroscopy (NIRS) to identify lipid-rich plaques. The concordance between these 2 imaging modalities has not been studied. Methods: 10 vessels were interrogated with both the Dragonfly OCT (pullback speed =20mm/sec) and the IVUS/Lipiscan catheter (pullback speed 0.5mm/sec). A fiduciary branch was identified for each pullback. Offline frame by frame analysis of the images was performed to identify lipid pools. By OCT, lipid-rich plaque was defined as a signal-poor region with diffuse borders.By NIRS, lipid-rich plaque was defined as a high lipid core burden index, which has been validated against histology. Results: There was excellent correlation between the spatial lipid pool distribution as noted on OCT and NIRS, with an average 5 mm discrepancy between the two modalities (possibly due to variations in guide catheter and wire position and imaging catheter positioning). An example appears in the Figure. Small lipid pools which did not extend beyond 1-2 frames were noted on only one or the other imaging system, which might be explained by the varying distance of the light source from the small lipid pool, differences in penetration, or false positives/negatives. www.JACC.TCTAbstracts2011
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Conclusion: There was very good correlation between the presence, absence, and spatial distribution of lipid pools as noted on OCT and NIRS imaging. Larger studies are required to determine whether NIRS and OCT provide complementary information for plaque characterization.
TCT-651
Assessment of the bioresorption process utilising intravascular ultrasound derived echogenicity analyses and vasomotion testing of the ABSORB bioresorbable everolimus-eluting vascular scaffold. A substudy of the ABSORB Cohort B trial Background: Reduction in the hyper-echogenicity characteristics of the ABSORB scaffold has been demonstrated to be related to the recovery of vasoreactivity of the scaffolded segment at 2 years. Subsequent changes in the platform design and manufacturing processes lead to significant prolongation in the lumen support with a new revision of the device . We sought to correlate the reduction in hyper-echogenicity of the revised ABSORB with the recovery of vaso-reactivity of the scaffolded segment during this time period. Methods: All patients from the ABSORB trial, who underwent paired echogenicity analyses and vasomotion testing at 6 (ABSORB Cohort B1) or 12 (ABSORB Cohort B2) months follow-up, were included in the analysis. Vasoreactivity was calculated as relative mean lumen diameter (MLD) changes from pre to post acetylcholine administration Results: Overall, 31 patients underwent paired IVUS derived echogenicity analyses and vasomotion testing at 6 (n=14) and 12-month (n=17) follow-up respectively. The reduction in hyper-echogenicity of the scaffolded segment in the acetylcholine test group went from 20.04±10.01 % to 18.09±10.01%, (p=0.561) and from 23.89 ± 9.99 % to 18.16 ± 8.70 % (p=0.006) at 6 and 12 months, respectively. The changes in MLD after administration of acethylcoline were 1% of vasodilation (p=0.405 ) and 4% vasoconstriction (p=0.086) at 6 and 12 months, respectively. A significant relationship between the changes in hyper-echogenicity and in MLD after acethylcoline administration was demonstrated at 12 months (Spearman rho=-0.678, p=0.0154), but not at 6 months (Spearman rho=-0.3778, p=0.252) Conclusion: The reduction in hyperechogenecity of the scaffolded segment is significantly correlated with the restoration of the vasomotor activities of a coronary segment scaffolded by the ABSORB scaffold at a long-term follow-up. This is consistent with the programmed loss of structural integrity of the scaffold at that time point.
TCT-652
In Background: Anatomo-pathological data indicate that coronary plaques prone to rupture and erosion tend to cluster within the proximal third of each coronary vessel. Intracoronary NIRS is a novel method to detect lipid core plaques (LCP). We sought to assess the spatial distribution of lipid core plaques (LCP) by means of near infra red spectroscopy (NIRS) in coronary arteries. Methods: Sixty-eight consecutive patients underwent NIRS imaging on a non culprit coronary artery. The region of interest (ROI) was subsequently divided into 10-mm segments from proximal to distal. The 2-mm long block chemogram value (probability of LCP, ranging from 0-low probability-to 1 -high probability) was assessed per ROI and per each 10-mm segment. Results: Overall, the length of the ROI was 58.0±4.3 mm, subdivided into 10-mm segments for a total of 392 analyzed segments. There was a progressive decrease of LCP from proximal to distal in the various 10-mm segments (1st 0. . While in LAD and in LCx, LCP tended to cluster in the proximal segment (p<0.001 and p=0.001, respectively), in the RCA they were evenly distributed along the artery (p=0.155). At logistic regression analysis, distance from the ostium was the only independent predictor of LCP. Conclusion: Lipid-core plaques, as detected by NIRS, cluster in the proximal segment of the coronary arteries, in distribution similar to that observed in prior autopsy studies. The distribution of LCP is similar to that of the culprit lesions of STEMI patients.
TCT-653
Quantitative . Serial change of quantitative (neointimal thickness, stent strut coverage and apposition at each strut) and qualitative characteristics were evaluated.
Results:
The incidence of uncovered stent strut significantly decreases from 9 months to 2 years follow-up (4.9 % to 2.6 %, p<0.001), but there was similar for malapposition rate (1.0 % to 1.1 %, p=0.63) and incidence of intracoronary thrombi (10.0 % to 8.8 %, p=0.79). In qualitative evaluation, lipid laden neointima (13.8% to 26.3%, p=0.03) and intimal disruption (13.8% to 33.8%, p=0.03) were more frequently detected at 2 years follow-up compared to 9 months follow-up.
Conclusion:
This OCT study suggested that neointimal coverage improved from 9 months to 2 years, but prevalence of malappostion and thrombus was not changed during extended follow-up. Additionally, the neoatherosclerosis including transforming into lipid laden neointima might progress between 9 months and 2 year-follow period.
TCT-654
Quantitative multi-modality imaging analysis of a fully bioresorbable scaffold: a head-to-head comparison between QCA, IVUS and OCT Results: 45 patients were sequentially imaged. OCT estimates scaffold length accurately compared to nominal length (95% CI of the difference: -0.15; 0.34 and -0.13; 0.47mm for baseline and 6 months, respectively), whereas QCA incurs consistent underestimation of the same magnitude at both time points (Pearson correlation = 0.806). IVUS yields low accuracy (95% CI of the difference: 1.04; 3.24 and -0.56; 2.65mm2 for baseline and 6 months, respectively), with several outliers and random variability test-retest. MLA decreases substantially between baseline and 6 months in QCA and OCT, but only minimally in IVUS (95% CI: 0.12, 0.52 mm2). ICCa and Bland-Altman show poor agreement for MLA between the different imaging modalities: worst agreement ED-IVUS post-implantation (ICCa 0.253); best agreement IVUS-OCT at 6 months (ICCa 0.767). All the pairs deviated significantly from linearity (p<0.01). Passing-Bablock non-parametric orthogonal regression showed constant and proportional bias between IVUS and OCT. Conclusion: OCT is the most accurate technique for measurement of scaffold length; QCA incurs systematic underestimation (foreshortening) and IVUS is the most inaccurate and unpredictable modality. This has implications for volumetric
